GEOVAX LABS, INC. Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two
GEOVAX LABS, INC. (GOVX) had Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two of $145.00 thousand as of 2012-09-30, per its 10-Q filed 2012-11-13.
Discontinued › Notes › Commitment and Contingencies › Unconditional Purchase Obligations (Excluding Capital Stock Redemptions) › Unrecorded Unconditional Purchase Obligation, Fiscal Year Maturity
us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary · last filed 2012-11-13
- 2012-09-30: Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two $145.00K.
- 2012-03-31: Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two $33.00K.
| Period end | Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two |
|---|---|
| 2012-09-30 | $145.00K 10-Q · filed 2012-11-13 |
| 2012-03-31 | $33.00K 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |